Cargando…
Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
Ovarian cancer (OvCa) is the gynaecological disorder with the poorest prognosis due to the fast development of chemoresistance. We sought to connect chemoresistance and cancer cell‐derived extracellular vesicles (EV). The mechanisms of how chemoresistance is sustained by EV remained elusive. One pot...
Autores principales: | Hugendieck, Gerrit, Lettau, Marcus, Andreas, Svenja, Neumann, Sabrina, Reinhardt, Natalie, Arnold, Philipp, Theilig, Franziska, Bastian, Lorenz, Rogmans, Christoph, Weimer, Jörg P., Flörkemeier, Inken, Wesch, Daniela, Arnold, Norbert, Maass, Nicolai, Janssen, Ottmar, Bauerschlag, Dirk, Hedemann, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323107/ https://www.ncbi.nlm.nih.gov/pubmed/37408115 http://dx.doi.org/10.1002/jev2.12338 |
Ejemplares similares
-
ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
por: Rogmans, Christoph, et al.
Publicado: (2021) -
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
por: Hedemann, Nina, et al.
Publicado: (2021) -
ADAM17 inhibition enhances platinum efficiency in ovarian cancer
por: Hedemann, Nina, et al.
Publicado: (2018) -
High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021) -
Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages
por: Rogmans, Christoph, et al.
Publicado: (2022)